| abstract |
The present invention relates to the identification of genes that are up-regulated by interferon-α administration and that correspond to the cDNA sequence described in SEQ ID No: 1. Measurement of the expression product of this gene has been proposed to be useful in predicting responsiveness to treatment with interferon-α acting on type 1 interferon receptors and other interferons. The use of the protein encoded by the gene for therapy is also contemplated. |